Well done Glenn and the team at Rhythm.
This ann also shows how confident RHY are about their cancer detection technology platform - which gives me more confidence about the upcoming TGA outcome.
Reading into the ann it appears they are making fairly timely progress identifying lead biomarkers for pan cancer candidates. Phase one complete. Now we get into the interesting phases.
Very organised and smooth operation.
Ann: RHY Advances Platform Expansion with Other Cancers, page-5
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
